Riparian Pharmaceuticals, Inc. — Form D

Riparian Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-12. The offering totals $3.0M, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-10-12
• Form: D
• Accession: 0001755048-18-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $500K
• Remaining: $2.5M
• Investors: 1
• Date of first sale: 2018-09-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-323482

Issuer

• Name: Riparian Pharmaceuticals, Inc.
• CIK: 0001755048
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 127 WESTERN AVENUE, BOSTON, MA, 02134
• Phone: 617-398-7784

Officers, directors & promoters (3)

More

• CIK 1755048 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search